Literature DB >> 20442330

Preclinical vascular disease identifies smokers at risk for COPD.

James D Crapo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20442330      PMCID： PMC2889364          DOI： 10.1073/pnas.1003826107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  17 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

Review 2.  Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality.

Authors:  Don D Sin; S F Paul Man
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests.

Authors:  Martine Remy-Jardin; Jean-Louis Edme; Charles Boulenguez; Jacques Remy; Ioana Mastora; Annie Sobaszek
Journal:  Radiology       Date:  2002-01       Impact factor: 11.105

4.  Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data.

Authors:  D M Mannino; C Brown; G A Giovino
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

5.  Alveolar septal structure in different species.

Authors:  R R Mercer; M L Russell; J D Crapo
Journal:  J Appl Physiol (1985)       Date:  1994-09

Review 6.  The potential impact of anaemia of chronic disease in COPD.

Authors:  T Similowski; A Agustí; W MacNee; B Schönhofer
Journal:  Eur Respir J       Date:  2006-02       Impact factor: 16.671

7.  Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers.

Authors:  B W M Willemse; N H T ten Hacken; B Rutgers; I G A T Lesman-Leegte; D S Postma; W Timens
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

Review 8.  Systemic effects of chronic obstructive pulmonary disease.

Authors:  A G N Agustí; A Noguera; J Sauleda; E Sala; J Pons; X Busquets
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

Review 9.  Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.

Authors:  James C Hogg
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

Review 10.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.

Authors:  W Q Gan; S F P Man; A Senthilselvan; D D Sin
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139
View more
  2 in total

1.  Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum.

Authors:  Stefan Röpcke; Olaf Holz; Gereon Lauer; Meike Müller; Susanne Rittinghausen; Peter Ernst; Gezim Lahu; Martin Elmlinger; Norbert Krug; Jens M Hohlfeld
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

2.  DNA methylation profiling in peripheral lung tissues of smokers and patients with COPD.

Authors:  Isaac K Sundar; Qiangzong Yin; Brian S Baier; Li Yan; Witold Mazur; Dongmei Li; Martha Susiarjo; Irfan Rahman
Journal:  Clin Epigenetics       Date:  2017-04-14       Impact factor: 6.551
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.